Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis
Mary J. Thomson, Anna S. F. Lok, Elliot B. Tapper – 10 September 2020
Environmental Pollution and the Developmental Origins of Childhood Liver Disease
Matthew C. Cave – 10 September 2020
Obesity and Liver Decompensation
Joseph C. Ahn, Vinay Sundaram – 9 September 2020
Nonalcoholic Fatty Liver Disease Risk Factors in Latin American Populations: Current Scenario and Perspectives
Claudia Pinto Marques Souza de Oliveira, Helma Pinchemel Cotrim, Marco Arrese – 9 September 2020
Patient With Nonalcoholic Steatohepatitis Posttransplant Develops Acute Hepatitis B Virus Causing Graft Failure
Amanda Chaney – 9 September 2020
Patients With Chronic Liver Disease/Cirrhosis Should Not Take Statin Medications
Christopher Kasia, Steven J. Scaglione – 9 September 2020
Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?
Ezequiel Ridruejo, Alejandro Soza – 9 September 2020
Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Daniel Berger, Vishal Desai, Sujit Janardhan – 9 September 2020
Pro: Noninvasive Imaging Has Replaced Biopsy as the Gold Standard in the Evaluation of Nonalcoholic Fatty Liver Disease
Shaham Mumtaz, Nathan Schomaker, Natasha Von Roenn – 9 September 2020
Identifying Quality Gaps in Preventive Care for Outpatients With Cirrhosis Within a Large, Academic Health Care System
Ani Kardashian, Arpan A. Patel, Elizabeth S. Aby, Vivy T. Cusumano, Camille Soroudi, Adam C. Winters, Eric Wu, Peter Beah, Sean Delshad, Nathan Kim, Liu Yang, Folasade P. May – 9 September 2020 – We sought to identify specific gaps in preventive care provided to outpatients with cirrhosis and to determine factors associated with high quality of care (QOC), to guide quality improvement efforts. Outpatients with cirrhosis who received care at a large, academic tertiary health care system in the United States were included.